Stock listing
ATX Stock Price, News, Filings & Events — Amplia Therapeutics Ltd.
Selected listing: ATX · ASX · AUD · AU
ATX:ASX is the public listing for Amplia Therapeutics Ltd., an Australian company specializing in innovative therapies for cancer and fibrotic diseases. With a market capitalization of around AUD 52.1 million, Amplia is actively advancing its drug candidates through clinical trials to meet critical healthcare needs. The company's focus on developing effective treatments positions it within a competitive landscape, where ongoing news and filings may impact its market presence.
- Ticker
- ATX:ASX
- Asset type
- Stock
- Market cap
- $52.1M
- Sector
- Health Technology
- Industry
- Biotechnology
- Exchange
- ASX
- Currency
- AUD
Amplia Therapeutics Ltd. ATX:ASX stock context
ATX:ASX is the public listing for Amplia Therapeutics Ltd., an Australian company specializing in innovative therapies for cancer and fibrotic diseases. With a market capitalization of around AUD 52.1 million, Amplia is actively advancing its drug candidates through clinical trials to meet critical healthcare needs. The company's focus on developing effective treatments positions it within a competitive landscape, where ongoing news and filings may impact its market presence.
Research Amplia Therapeutics Ltd.
Amplia Therapeutics Ltd. investor report
Review AI stock analysis and investor report context for ATX:ASX.
Amplia Therapeutics Ltd. company profile
View the public company page for Amplia Therapeutics Ltd. on 6ix.
Amplia Therapeutics Ltd. news
Read company news and market updates connected to Amplia Therapeutics Ltd..
Amplia Therapeutics Ltd. investor events
Find investor webinars, events, and replay context for Amplia Therapeutics Ltd..